Investor Relations

News Releases

<< Back
May 29, 2018
Intersect ENT to Present at William Blair & Company 38th Annual Growth Stock Conference

MENLO PARK, Calif.--(BUSINESS WIRE)--May 29, 2018-- Intersect ENT, Inc. (Nasdaq: XENT) today announced that management will present at the 38th Annual William Blair Growth Stock Conference.

The presentation is scheduled for June 12, 2018 at 11:30 a.m. CT at the Four Seasons Hotel in Chicago, Ill.

A webcast will be available online from the Investor Relations page of the company's website at www.IntersectENT.com. The webcast replay will be available for approximately one month.

About Intersect ENT®

Intersect ENT is dedicated to transforming ear, nose and throat care by providing innovative, clinically meaningful therapies to physicians and patients. The company’s steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the company’s unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care.

For additional information on the company or its products, including risks and benefits, please visit www.IntersectENT.com.

XENT-F

Source: Intersect ENT

Intersect ENT
Jeri Hilleman, 650-641-2105
ir@intersectENT.com